# BST-DERMON Versus Standard of Care in the Treatment of Diabetic Foot Ulcers

> **NCT00434538** · PHASE3 · TERMINATED · sponsor: **BioSyntech Canada Inc.** · enrollment: 40 (actual)

## Conditions studied

- Diabetic Foot Ulcer

## Interventions

- **DEVICE:** BST-DermOn

## Key facts

- **NCT ID:** NCT00434538
- **Lead sponsor:** BioSyntech Canada Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-02
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 40 (ACTUAL)
- **Why stopped:** Due to Sponsor's financial reasons
- **Last updated:** 2009-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00434538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00434538, "BST-DERMON Versus Standard of Care in the Treatment of Diabetic Foot Ulcers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00434538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*